Typhoid Vaccine Clinical Trial in Nepal: Phase III Results
Phase III clinical trial of a typhoid conjugate vaccine conducted over 20,000 children in Kathmandu, Nepal, is highly immunogenic, safe and effective for vaccinating children at high risk.
from Medindia Latest Updates https://ift.tt/36pTgC4
Phase III clinical trial of a typhoid conjugate vaccine conducted over 20,000 children in Kathmandu, Nepal, is highly immunogenic, safe and effective for vaccinating children at high risk.
No comments:
Post a Comment